InvestorsHub Logo
Followers 11
Posts 658
Boards Moderated 0
Alias Born 12/21/2004

Re: None

Monday, 02/15/2016 5:54:58 PM

Monday, February 15, 2016 5:54:58 PM

Post# of 106
GhostInTheMatrix:

Thanks for this Zika virus IHUB message board. Below is some basic DD on Aethlon Medical (NASDAQ - AEMD) as you requested hopefully to be added to the ZIKA virus (Shorts and Longs) (ZIKA) message board.

I urge all here to explore Aethlon Medical at the links provided below.

Thanks again. Best to all here. Enjoy dp

AEMD- Aethlon Medical - http://www.aethlonmedical.com/

About The Aethlon Hemopurifier®

Of the hundreds of viruses known to be infectious to man, antiviral drug therapies are approved for fewer than ten. The Aethlon Hemopurifier® provides a broad-spectrum therapeutic strategy to address drug resistant viral pathogens. To date, Hemopurifier therapy has been administered to individuals infected with Ebola virus (Ebola), Hepatitis C virus (HCV) and the Human Immunodeficiency virus (HIV). Time Magazine recently named the Hemopurifier to their list of “Top 25 Inventions" and "The 11 Most Remarkable Advances in Healthcare." Beyond human treatment experiences, pre-clinical Hemopurifier studies have validated the capture of some of world’s deadliest pathogens. These include: Dengue hemorrhagic virus, Lassa hemorrhagic virus, H5N1 avian influenza virus, H1N1 swine flu virus, the reconstructed 1918 influenza virus, West Nile virus, Zika virus and Vaccinia and Monkeypox, which serve as models for human smallpox infection. U.S. clinical progression of Hemopurifier therapy is being advanced under FDA approved clinical studies.

Aethlon is also investigating the use of Hemopurifier therapy to capture tumor-derived exosomes, a significant unaddressed therapeutic target in cancer care. Tumor-derived exosomes promote cancer progression through multiple mechanisms, which include seeding the spread of metastasis and direct suppression of the immune response.

Link to most recent webcast at Source Capital Conference on Feb 10, 2016 in New York City:

http://wsw.com/webcast/sourcecap1/aemd/index.aspx

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.